Joon-Young Kim Selected Research

Vascular System Injuries

1/2014	Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms.
10/2009	Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
4/2009	Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joon-Young Kim Research Topics

Disease

4	Vascular Calcification 01/2016 - 04/2010
3	Atherosclerosis 11/2015 - 04/2009
3	Hyperplasia 01/2014 - 10/2009
3	Vascular System Injuries 01/2014 - 04/2009
3	Neoplasms (Cancer) 01/2013 - 03/2007
2	Infections 03/2024 - 11/2010
2	Glaucoma 07/2021 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2015 - 02/2012
2	Fibrosis (Cirrhosis) 02/2012 - 01/2012
2	Intervertebral Disc Displacement (Herniated Disc) 01/2010 - 07/2007
1	Endoleak 03/2024
1	Aneurysm (Aneurysms) 03/2024
1	Kidney Diseases (Kidney Disease) 02/2024
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2024
1	Blister (Bulla) 07/2021
1	Fistula 01/2021
1	Vascular Remodeling 01/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014
1	Cerebral Palsy (Spastic Diplegia) 07/2013
1	Neonatal Jaundice 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Ureteral Obstruction 01/2012
1	Hypercalciuria 05/2011
1	Urolithiasis 05/2011
1	Thrombosis (Thrombus) 11/2010
1	Type 2 Diabetes Mellitus (MODY) 04/2010
1	Back Pain (Backache) 01/2010
1	Carcinogenesis 10/2008
1	Body Weight (Weight, Body) 07/2004
1	Dosage-sensitive sex reversal 05/2004
1	Familial Hypoadrenocorticism 05/2004

Drug/Important Bio-Agent (IBA)

2	CollagenIBA 07/2021 - 01/2018
2	pyruvate dehydrogenase kinase 4IBA 01/2016 - 11/2015
2	Phosphates (Orthophosphate)IBA 11/2015 - 02/2012
2	quinone (benzoquinone)IBA 01/2014 - 04/2009
2	Oxidoreductases (Dehydrogenase)IBA 01/2014 - 04/2009
2	Dimethyl FumarateIBA 01/2014 - 01/2012
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2013 - 10/2008
2	AntioxidantsIBA 02/2012 - 11/2010
2	Thioctic Acid (Lipoic Acid)IBA 02/2012 - 11/2010
2	Collagen Type I (Type I Collagen)IBA 02/2012 - 01/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2012 - 01/2012
1	MucinsIBA 01/2024
1	Mucin-4IBA 01/2024
1	CA-125 Antigen (CA 125 Antigen)IBA 01/2024
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2024
1	CytokinesIBA 01/2024
1	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2024
1	collagen-glycosaminoglycan copolymerIBA 07/2021
1	Ophthalmic Solutions (Eye Drops)IBA 07/2021
1	Contrast MediaIBA 01/2021
1	CalciumIBA 11/2015
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 11/2015
1	NF-E2-Related Factor 2IBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	AgarIBA 01/2013
1	scoparoneIBA 01/2013
1	Caspase 9IBA 02/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012
1	sulforaphaneIBA 02/2012
1	Cytochromes c (Cytochrome c)IBA 02/2012
1	Adenosine Triphosphate (ATP)IBA 02/2012
1	Fibronectins (Fibronectin)IBA 01/2012
1	Calcium-Sensing ReceptorsIBA 05/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2011
1	Genetic Markers (Genetic Marker)IBA 05/2011
1	Calcium OxalateIBA 05/2011
1	p38 Mitogen-Activated Protein KinasesIBA 11/2010
1	RNA (Ribonucleic Acid)IBA 11/2010
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 04/2010
1	OsteoprotegerinIBA 04/2010
1	ectonucleotide pyrophosphatase phosphodiesterase 1IBA 04/2010
1	ClusterinIBA 10/2009
1	PyransIBA 04/2009
1	beta-lapachoneIBA 04/2009
1	Antineoplastic Agents (Antineoplastics)IBA 04/2009
1	NAD (NADH)IBA 04/2009
1	Serine (L-Serine)FDA Link 10/2008
1	Tyrosine (L-Tyrosine)FDA Link 10/2008
1	Oxygen (Dioxygen)IBA 07/2007
1	OzoneIBA 07/2007
1	PPAR gammaIBA 03/2007
1	Estrogen Receptor alphaIBA 03/2007
1	cyclopentenoneIBA 03/2007
1	NucleotidesIBA 07/2004
1	Amino Acids FDA Link 05/2004
1	Orphan Nuclear ReceptorsIBA 05/2004

Therapy/Procedure

2	Stents 03/2024 - 11/2010
2	Therapeutics 04/2009 - 07/2007
1	Kidney Transplantation 02/2024
1	Liver Transplantation 02/2024
1	Osteotomy 07/2013
1	Ligation 02/2012
1	Drug-Eluting Stents 11/2010
1	Electroacupuncture 01/2010
1	Aftercare (After-Treatment) 07/2007